AzTrials
AzTrials

Stuttering, AdultNCT07389694

Using Transcranial Magnetic Stimulation to Treat Stuttering

A study testing Transcranial Magnetic Stimulation in people with Stuttering, Adult, run by Kansas State University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if repeated transcranial magnetic stimuli (rTMS) can treat stuttering in adults. The main questions it aims to answer are: Will there be changes in the brains of people who stutter because of the treatment? Will any changes in the brain result in less stuttering?… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Stuttering, Adult
What is being tested?
Transcranial Magnetic Stimulation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited States
Study dates
15 Feb 2026to 15 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age from 18 to 65 years
  • Self-identifies as a person who currently stutters
  • Right-handed or left-handed
  • Normal hearing and (corrected) vision
  • Able to understand and give informed consent
  • Monolingual English speaker

Who cannot join

  • Cardiac pacemaker or pacemaker wires; neurostimulators; implanted pumps
  • Metal in the body (rods, plates, screws, shrapnel, dentures, IUD) or metallic particles in the eye
  • Facial tattoos
  • Not having medical insurance
  • Surgical clips in the head or previous neurosurgery
  • Any magnetic particles in the body
Show all 21Show fewer
  • Cochlear implants
  • Prosthetic heart valves
  • Epilepsy or any other type of seizure history
  • History of significant head trauma (i.e., extended loss of consciousness, neurological sequelae)
  • Known structural brain lesions
  • Pre-existing speech, language, or neurological disorder (except for stuttering)
  • Significant other disease (heart disease, malignant tumors, mental disorders)
  • Significant claustrophobia; Ménière's disease
  • Women who are trying to get pregnant and sexually active women (of reproductive age) not on a reliable contraceptive
  • Pregnancy, breastfeeding
  • Medications increasing the risk for seizures
  • Non-prescribed drug use
  • Use of recreational drugs such as medical marijuana
  • Failure to perform the behavioral tasks or neuropsychological evaluation tests
  • Prisoners

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Kristin Pelczarski, Ph.D. contact

785-532-6879

kpelczar@ksu.edu

Julio Hernandez Pavon, Ph.D., DSc contact

juliohpavon@ksu.edu

United States1 site, 1 recruiting
  • Bluemont Hall, Department of Psychological Sciences, Kansas State University

    Manhattan, Kansas, 66506-7500

    Julio Hernandez Pavon, Ph.D., D.Sc., 785-532-0805, juliohpavon@ksu.edu

    Julio Hernandez Pavon, Ph.D., D.Sc.

    Recruiting

Other trials in United States

About this study

Official title: Modulating Bilateral Cortical Activation In Adults Who Stutter: A Pilot Study

The goal of this clinical trial is to learn if repeated transcranial magnetic stimuli (rTMS) can treat stuttering in adults. The main questions it aims to answer are:

  • Will there be changes in the brains of people who stutter because of the treatment?
  • Will any changes in the brain result in less stuttering?

Participants will:

  • Visit the lab 3 times before treatment for tests
  • Complete 10 rTMS sessions
  • Visit the lab 2 times after treatment for tests
Read the detailed description

Measures must be obtained to in preparation for TMS treatment. Structural MRI and resting-state functional MRI (rsfMRI) recordings will be obtained from the participant, and they will undergo a neuronavigational session to determine best placement for the electrodes.

MRI/rsfMRI recordings: The structural MRIs will be obtained and used for TMS neuronavigation. Resting-state functional MRI will be recorded for 8 min with the eyes open. rTMS will be delivered at 10 Hz for 10 min with a stimulation intensity of 120% of the resting motor threshold (rMT).

Neuronavigation: The TMS coil will be navigated with a neuronavigation system using the individual MRIs. rTMS targets: rTMS will be delivered to the left inferior frontal gyrus (IFG). We will use the neuronavigation system to identify the IFG.

Three pre-treatment and 2 post-treatment sessions will each obtain data from the following measurements:

  • rs-EEG: rs-EEG responses will be recorded with eyes open for 5 minutes using a 64-channel EEG system.
  • Eye tracker: eye gaze fixations, dwell time, saccades, and gaze durations will be recorded while the participant completes several behavioral phonological memory tasks.
  • Spontaneous speech sample will be obtained to determine percent syllables stuttered.
Keywords
stuttering, noninvasive treatment, transcranial magnetic stimulation, eye tracking, EEG
Medical subject headings
Stuttering

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcranial Magnetic StimulationDevice

    This study uses Transcranial Magnetic Stimulation (TMS) applied to specific speech and motor areas of the brain to stimulate cortical areas that experience reduced activations during left-hemisphere dominant tasks in people who stutter.

Study groups in NCT07389694
Study groupRoleWhat they receive
Transcranial Magnetic Stimulation to treat stutteringExperimentalThere is only one arm to this study. All participants will receive 10 days of Transcranial Magnetic Stimulation to specific cortical speech and motor areas.
Receives: Device: Transcranial Magnetic Stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in functional connectivity with resting-state electroencephalography (rs-EEG)

    A seed-based functional connectivity analysis will be carried out between the two stimulated brain areas. To assess the changes in effective connectivity, the investigators will compare the seed-based connectivity values across sessions.

    Measured: Baseline, immediately post-treatment, and one week after post-treatment.

  2. Changes in behavioral measures of stuttering and phonological processing.

    To assess functional changes as a result of rTMS treatment, comparison of eye tracking measurements of duration, dwell time, and number of fixations of eye movements while completing speech and language-based tasks are compared across sessions.

    Measured: Baseline, immediately post-treatment, and one week after post-treatment.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2026
  2. Study start15 Feb 2026
  3. Primary completion15 Dec 2027 (estimated)
  4. Study completion15 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Repeated measures, single subject design
Masking
None (open label)
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07389694
Sponsor's protocol ID
KPelczarski
Status last verified
Feb 2026
First submitted
29 Jan 2026
Last updated
5 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: IPD used in the results publication with be shared with other researchers.

Publications

  • Ridding MC, Rothwell JC. Is there a future for therapeutic use of transcranial magnetic stimulation? Nat Rev Neurosci. 2007 Jul;8(7):559-67. doi: 10.1038/nrn2169.

    PubMed 17565358
  • Hernandez-Pavon JC, Harvey RL. Noninvasive Transcranial Magnetic Brain Stimulation in Stroke. Phys Med Rehabil Clin N Am. 2019 May;30(2):319-335. doi: 10.1016/j.pmr.2018.12.010. Epub 2019 Feb 21.

    PubMed 30954150
  • Hernandez-Pavon JC, Veniero D, Bergmann TO, Belardinelli P, Bortoletto M, Casarotto S, Casula EP, Farzan F, Fecchio M, Julkunen P, Kallioniemi E, Lioumis P, Metsomaa J, Miniussi C, Mutanen TP, Rocchi L, Rogasch NC, Shafi MM, Siebner HR, Thut G, Zrenner C, Ziemann U, Ilmoniemi RJ. TMS combined with EEG: Recommendations and open issues for data collection and analysis. Brain Stimul. 2023 Mar-Apr;16(2):567-593. doi: 10.1016/j.brs.2023.02.009. Epub 2023 Feb 23.

    PubMed 36828303
  • Pelczarski KM, Tendera A, Dye M, Loucks TM. Delayed Phonological Encoding in Stuttering: Evidence from Eye Tracking. Lang Speech. 2019 Sep;62(3):475-493. doi: 10.1177/0023830918785203. Epub 2018 Jul 6.

    PubMed 29976115
  • Pelczarski KM, Yaruss JS. Phonological memory in young children who stutter. J Commun Disord. 2016 Jul-Aug;62:54-66. doi: 10.1016/j.jcomdis.2016.05.006. Epub 2016 May 17.

    PubMed 27280891
  • Pelczarski KM, Yaruss JS. Phonological encoding of young children who stutter. J Fluency Disord. 2014 Mar;39:12-24. doi: 10.1016/j.jfludis.2013.10.003. Epub 2013 Nov 20.

    PubMed 24759190
  • Byrd CT, McGill M, Usler E. Nonword repetition and phoneme elision in adults who do and do not stutter: Vocal versus nonvocal performance differences. J Fluency Disord. 2015 Jun;44:17-31. doi: 10.1016/j.jfludis.2015.01.004. Epub 2015 Jan 24.

    PubMed 25680736
  • Anderson JD, Wagovich SA, Hall NE. Nonword repetition skills in young children who do and do not stutter. J Fluency Disord. 2006;31(3):177-99. doi: 10.1016/j.jfludis.2006.05.001. Epub 2006 Jun 30.

    PubMed 16814376
  • Strand F, Forssberg H, Klingberg T, Norrelgen F. Phonological working memory with auditory presentation of pseudo-words -- an event related fMRI Study. Brain Res. 2008 May 30;1212:48-54. doi: 10.1016/j.brainres.2008.02.097. Epub 2008 Mar 18.

    PubMed 18442810
  • Perrachione TK, Ghosh SS, Ostrovskaya I, Gabrieli JDE, Kovelman I. Phonological Working Memory for Words and Nonwords in Cerebral Cortex. J Speech Lang Hear Res. 2017 Jul 12;60(7):1959-1979. doi: 10.1044/2017_JSLHR-L-15-0446.

    PubMed 28631005
  • Neef NE, Anwander A, Butfering C, Schmidt-Samoa C, Friederici AD, Paulus W, Sommer M. Structural connectivity of right frontal hyperactive areas scales with stuttering severity. Brain. 2018 Jan 1;141(1):191-204. doi: 10.1093/brain/awx316.

    PubMed 29228195
  • Neef NE, Hoang TN, Neef A, Paulus W, Sommer M. Speech dynamics are coded in the left motor cortex in fluent speakers but not in adults who stutter. Brain. 2015 Mar;138(Pt 3):712-25. doi: 10.1093/brain/awu390. Epub 2015 Jan 15.

    PubMed 25595146

Questions about this trial

What is this clinical trial studying?

A study testing Transcranial Magnetic Stimulation in people with Stuttering, Adult, run by Kansas State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 21 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kristin Pelczarski, Ph.D. (785-532-6879, kpelczar@ksu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in functional connectivity with resting-state electroencephalography (rs-EEG) (time frame: Baseline, immediately post-treatment, and one week after post-treatment.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07389694, which also lists 12 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in